Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/jcmm.15364 http://scihub22266oqcxt.onion/10.1111/jcmm.15364 32320516!7264656!32320516     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Cell+Mol+Med 2020 ; 24 (12): 6558-6570 Nephropedia Template TP {{tp|p=32320516|t=2020. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months |pdf=|usr=}}{{32320516}} gab.com Text Scientific research progress of COVID-19/SARS-CoV-2 in the first five months JO: J Cell Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=32320516 #FOAvip A cluster of pneumonia (COVID-19) cases have been found in Wuhan China in late December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was identified to be the aetiological virus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2), which has a phylogenetic similarity to severe acute respiratory syndrome coronavirus (SARS-CoV). SARS-CoV-2 transmits mainly through droplets and close contact and the elder or people with chronic diseases are high-risk population. People affected by SARS-CoV-2 can be asymptomatic, which brings about more difficulties to control the transmission. COVID-19 has become pandemic rapidly after onset, and so far the infected people have been above 2 000 000 and more than 130 000 died worldwide according to COVID-19 situation dashboard of World Health Organization (https://covid19.who.int). Here, we summarized the current known knowledge regarding epidemiological, pathogenesis, pathology, clinical features, comorbidities and treatment of COVID-19/ SARS-CoV-2 as reference for the prevention and control COVID-19. Twit Text FOAVip Scientific research progress of COVID-19/SARS-CoV-2 in the first five months ????J Cell Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=32320516 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32320516 #FOAvip English Wikipedia <ref>{{Cite pmid|32320516}}</ref> Scientific research progress of COVID-19/SARS-CoV-2 in the first five months #MMPMID32320516 Li H; Liu Z; Ge J J Cell Mol Med 2020[Jun]; 24 (12): 6558-6570 PMID32320516show ga A cluster of pneumonia (COVID-19) cases have been found in Wuhan China in late December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was identified to be the aetiological virus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2), which has a phylogenetic similarity to severe acute respiratory syndrome coronavirus (SARS-CoV). SARS-CoV-2 transmits mainly through droplets and close contact and the elder or people with chronic diseases are high-risk population. People affected by SARS-CoV-2 can be asymptomatic, which brings about more difficulties to control the transmission. COVID-19 has become pandemic rapidly after onset, and so far the infected people have been above 2 000 000 and more than 130 000 died worldwide according to COVID-19 situation dashboard of World Health Organization (https://covid19.who.int). Here, we summarized the current known knowledge regarding epidemiological, pathogenesis, pathology, clinical features, comorbidities and treatment of COVID-19/ SARS-CoV-2 as reference for the prevention and control COVID-19. |*Pandemics[MESH] |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Amides/therapeutic use[MESH] |Angiotensin-Converting Enzyme 2[MESH] |Angiotensin-Converting Enzyme Inhibitors/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus/*drug effects/immunology/pathogenicity[MESH] |COVID-19[MESH] |COVID-19 Serotherapy[MESH] |COVID-19 Testing[MESH] |COVID-19 Vaccines[MESH] |Clinical Laboratory Techniques[MESH] |Coronavirus Infections/diagnosis/*drug therapy/*epidemiology/immunology/prevention & control/therapy[MESH] |Disease Progression[MESH] |Gene Expression Regulation[MESH] |Host-Pathogen Interactions/genetics/immunology[MESH] |Humans[MESH] |Immunization, Passive/methods[MESH] |Peptidyl-Dipeptidase A/genetics/immunology[MESH] |Pneumonia, Viral/diagnosis/*drug therapy/*epidemiology/immunology[MESH] |Pyrazines/therapeutic use[MESH] |SARS-CoV-2[MESH] |Severity of Illness Index[MESH] |Spike Glycoprotein, Coronavirus/antagonists & inhibitors/*genetics/immunology[MESH]Scientific research progress of COVID-19/SARS-CoV-2 in the first five (epmc).pdf DeepDyve Pubget Overpricing